Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention

Aims: Cardiovascular risk persists despite intensive lipid lowering therapy using statins. Serum levels of lipoprotein (a) [Lp(a)] can be a residual cardiovascular risk for adverse events. Aim of the present study was to evaluate the impact of Lp(a) on long-term clinical outcomes in patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Suwa, Satoru, Ogita, Manabu, Miyauchi, Katsumi, Sonoda, Taketo, Konishi, Hirokazu, Tsuboi, Shuta, Wada, Hideki, Naito, Ryo, Dohi, Tomotaka, Kasai, Takatoshi, Okazaki, Shinya, Isoda, Kikuo, Daida, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5684478/
https://ncbi.nlm.nih.gov/pubmed/28321012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.38794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados